Feline Hyperthyroidism

Feline hyperthyroidism (FHT) is the most common endocrine disorder of cats, characterized by excessive production and secretion of thyroid hormones (primarily thyroxine, T4, and triiodothyronine, T3) from an abnormally enlarged thyroid gland [4]. The disease was first described in the veterinary literature in 1979–1980 and has since become a routinely managed condition in primary care practice [4]. It predominantly affects middle-aged to older cats, with the vast majority of cases occurring in cats over 10 years of age [4]. Because hyperthyroidism exerts systemic effects on nearly every organ system, it frequently coexists with — and can mask — other common geriatric conditions such as chronic kidney disease (CKD), making comprehensive management particularly challenging [2].

Primary Cause: In more than 97–98% of cases, feline hyperthyroidism is caused by functional adenomatous hyperplasia (multinodular goiter) or a thyroid adenoma involving one or both thyroid lobes [4]. Thyroid carcinoma accounts for fewer than 2–3% of cases and should be suspected when the gland is very large, firmly fixed, or invasive [4].

Pathological Mechanism: The adenomatous thyroid tissue autonomously produces and secretes excessive T4 and T3, independent of normal pituitary TSH (thyroid-stimulating hormone) regulation [4]. The resulting hyperthyroid state drives a global increase in metabolic rate, oxygen consumption, and thermogenesis. Elevated thyroid hormones upregulate beta-adrenergic receptors, producing tachycardia, increased cardiac output, and systemic vasodilation [4].

Renal Effects: Hyperthyroidism causes significant increases in renal blood flow and glomerular filtration rate (GFR), as well as protein catabolism that elevates creatinine production [3]. This creates a paradox: in a hyperthyroid cat with concurrent CKD, the elevated GFR artificially lowers plasma creatinine and symmetric dimethylarginine (SDMA) into the reference range, masking underlying renal insufficiency [2][3]. When hyperthyroidism is treated and thyroid hormone levels normalize, GFR decreases, and previously hidden CKD may become apparent [2][3].

Cardiovascular Effects: Chronic thyroid hormone excess stimulates cardiac hypertrophy, particularly hypertrophy of the left ventricle, and increases cardiac output. This can lead to hypertrophic cardiomyopathy, congestive heart failure, and contributes to systemic hypertension [4][6].

Hypertension: Systemic hypertension occurs in a significant proportion of hyperthyroid cats, either as a direct consequence of the hyperdynamic circulation or in association with concurrent CKD [6]. This predisposes cats to target organ damage, particularly retinal detachment, renal injury, and cerebrovascular events [6].

Risk Factors and Proposed Etiologies: The precise etiology of autonomous thyroid nodule development remains incompletely understood. Proposed contributing factors include dietary iodine imbalance, exposure to environmental goitrogens (e.g., polybrominated diphenyl ethers in household dust and certain commercial cat food constituents), and genetic predispositions [4]. Indoor cats consuming canned food diets — particularly fish- and liver-flavored varieties — appear to have a higher prevalence in epidemiological studies [4].

Diagnosis of feline hyperthyroidism is based on the integration of history, clinical signs, physical examination findings, and confirmatory laboratory testing [1][4].

Physical Examination: Cervical palpation for thyroid enlargement (goiter) is an essential part of the examination; a palpable thyroid nodule is found in most affected cats [4]. Cardiac auscultation for tachycardia, murmur, or gallop rhythm and blood pressure measurement (to screen for hypertension) should be performed in all suspected cases [6].

Laboratory Diagnostics:

Thyroid Hormone Measurement:

• ·Baseline serum total T4 (TT4): The primary screening and diagnostic test. TT4 is elevated above the reference interval in the majority of hyperthyroid cats [1][4]. A markedly elevated TT4 in a cat with compatible clinical signs is diagnostic.
• ·"High-normal" TT4 / borderline cases: Some cats with early or mild hyperthyroidism have TT4 values within the upper reference range. In these cases, serial retesting (2–4 weeks later), free T4 by equilibrium dialysis (fT4-ED), or a T3 suppression test may be indicated [4].
• ·Free T4 by equilibrium dialysis (fT4-ED): More sensitive than TT4; used as a second-tier test when TT4 is equivocal. Increased fT4-ED with consistent clinical signs supports diagnosis [4].
• ·Endogenous TSH: Suppressed (low or undetectable) TSH further supports hyperthyroidism; however, TSH assays validated for cats were not widely available at the time of many guideline publications, and their sensitivity is still under refinement [1][4].
• ·Technetium-99m (99mTc) thyroid scintigraphy: Highly sensitive and specific; identifies ectopic thyroid tissue, bilateral vs. unilateral involvement, and differentiates hyperplasia from carcinoma. Best used pre-surgically or prior to radioiodine therapy [4][5].

Routine Hematology and Biochemistry — Common Findings:

• ·ALT (alanine aminotransferase): Elevated in the majority of hyperthyroid cats (hepatic lipidosis-like changes due to increased hepatic metabolism); normalizes with treatment [4]
• ·ALP (alkaline phosphatase): Frequently elevated [4]
• ·BUN (blood urea nitrogen): May be elevated due to increased protein catabolism; however, concurrent CKD can also elevate BUN [3]
• ·Creatinine (CREA): Often low-normal or genuinely low due to muscle wasting and elevated GFR; may increase after treatment and unmask CKD [2][3]
• ·SDMA: Similarly suppressed in active hyperthyroidism; serial monitoring post-treatment recommended [3]
• ·Phosphorus: May be elevated (renal effects) [3]
• ·HCT (hematocrit) / RBC: Mild erythrocytosis (increased PCV/HCT) is common in hyperthyroid cats due to increased erythropoiesis stimulated by thyroid hormones [4]
• ·Lymphopenia and eosinopenia: Stress leukogram is common [4]
• ·Platelets (PLT): Generally unremarkable
• ·Albumin (ALB) / Total protein: May be low-normal to mildly decreased due to protein catabolism and muscle wasting [4]
• ·Potassium: Hypokalemia may be present and contribute to muscle weakness [4]

Urinalysis: Urine specific gravity (USG) may be decreased due to hyperthyroidism-associated PU/PD or concurrent CKD; urine protein:creatinine ratio (UPC) should be evaluated [2][3].

Imaging:

• ·Thoracic radiography: Cardiomegaly, pleural effusion, or pulmonary edema may be present in cats with cardiac complications [4]
• ·Echocardiography: Recommended when cardiac disease is suspected; helps differentiate hyperthyroid cardiomyopathy from primary cardiac disease [4]
• ·Abdominal ultrasound: Useful for screening concurrent conditions, including CKD [2]

Blood Pressure Measurement: All hyperthyroid cats should be screened for systemic hypertension (systolic BP ≥160 mmHg warrants treatment consideration; ≥180 mmHg is associated with high risk of target organ damage) [6].

Four main treatment modalities are available, each with distinct advantages, disadvantages, and quality-of-life implications for the cat and owner [5].

1. Medical Management (Antithyroid Drugs)

Methimazole (oral or transdermal) and carbimazole (a methimazole prodrug available in some countries) are the most commonly used medical therapies [1][4][5].

• ·Mechanism: Block thyroid peroxidase, thereby inhibiting thyroid hormone synthesis [4]
• ·Dosing: Methimazole typically started at 1.25–2.5 mg PO BID and adjusted based on TT4 monitoring [1][4]
• ·Transdermal methimazole (applied to the inner pinna): A viable alternative for cats that are difficult to medicate orally; efficacy is slightly lower than oral form [5]
• ·Monitoring: TT4, renal parameters (BUN, creatinine, SDMA), CBC, and blood pressure should be rechecked at 2–4 weeks, then at 3-month intervals once stable [1][4]
• ·Advantages: Reversible (important when assessing for occult CKD), low cost, widely available; allows a therapeutic trial before committing to permanent therapy [5]
• ·Disadvantages: Requires lifelong twice-daily administration; adverse effects include facial pruritus, excoriation, vomiting, anorexia, hepatotoxicity, thrombocytopenia, and granulocytopenia [4][5]
• ·Renal monitoring during treatment: Because treating hyperthyroidism reduces GFR, renal function should be carefully monitored 4 weeks after initiating therapy. If azotemia worsens significantly, dose reduction or treatment reassessment is warranted [2][3]

2. Dietary (Nutritional) Management

• ·Low-iodine diet (e.g., Hill's Prescription Diet y/d): Limits iodine availability, thereby reducing thyroid hormone synthesis [5]
• ·Efficacy: Can normalize TT4 in many cats when the diet is fed exclusively; however, strict dietary exclusivity is required (no treats, supplements, or other foods) [5]
• ·Advantages: Reversible, non-invasive, no daily medication [5]
• ·Disadvantages: Dietary compliance is difficult in multi-cat households or outdoor cats; palatability issues reported in some cats; nutritional adequacy questions with long-term use [5]

3. Surgical Thyroidectomy

• ·Procedure: Unilateral or bilateral thyroidectomy; bilateral disease requires staged procedures or special surgical techniques to preserve parathyroid glands [4][5]
• ·Advantages: Potentially curative in a single procedure [5]
• ·Disadvantages: General anesthesia risk (increased in cats with cardiac disease or hypertension — requires medical stabilization pre-operatively); risk of iatrogenic hypothyroidism; risk of transient or permanent hypoparathyroidism (hypocalcemia) following bilateral thyroidectomy [4][5]
• ·Pre-operative preparation: Antithyroid drugs for 2–4 weeks prior to surgery to reduce cardiovascular risk [4]
• ·Post-operative monitoring: Serum calcium monitoring for 48–72 hours; TT4 monitoring to confirm euthyroidism [4]

4. Radioactive Iodine (¹³¹I) Therapy

• ·Mechanism: Radioactive iodine is selectively taken up by hyperfunctional thyroid tissue and destroys it via beta radiation, while normal (suppressed) tissue and other organs receive minimal radiation [4][5]
• ·Advantages: Considered the gold-standard curative treatment; single treatment is curative in ~95% of cases; no anesthesia required; minimal side effects [4][5]
• ·Disadvantages: Availability limited to licensed facilities; requires a period of hospitalization and radiation isolation (typically 1–2 weeks depending on local regulations); higher upfront cost; rarely causes hypothyroidism (requiring thyroid supplementation) [5]
• ·Special considerations: In cats with suspected concurrent CKD, the irreversible nature of ¹³¹I means that a medical trial is often recommended first to assess renal function after TT4 normalization before committing to permanent therapy [2][3][5]

Management of Concurrent Conditions

• ·Systemic hypertension: Amlodipine (0.625–1.25 mg PO SID) is the first-line antihypertensive agent; should be initiated if systolic BP ≥160–180 mmHg or target organ damage is present [6]
• ·Concurrent CKD: Management requires careful balancing of thyroid control vs. renal perfusion; overly aggressive reduction of TT4 can worsen azotemia [2][3]. Regular monitoring of renal parameters is essential during and after treatment [1][2]
• ·Hypertrophic cardiomyopathy: Often improves with successful treatment of hyperthyroidism; atenolol may be used for rate control if needed perioperatively [4]
• ·Potassium supplementation: If hypokalemia is documented and contributing to weakness [4]

The prognosis for feline hyperthyroidism is generally favorable to excellent with appropriate treatment, particularly when the disease is diagnosed before severe cardiovascular, hypertensive, or renal complications develop [4][5].

Treatment Outcomes:

• ·Radioactive iodine (¹³¹I): Single-treatment cure rate is approximately 95% or higher, making it the most effective curative option [4][5]. Most cats return to euthyroid status within 1–3 months. Post-treatment hypothyroidism occurs in a small percentage and requires thyroid hormone supplementation [5].
• ·Surgical thyroidectomy: Long-term cure rates are high when disease is unilateral or complete bilateral thyroidectomy is achieved; recurrence may occur if ectopic thyroid tissue is present [4][5].
• ·Medical and dietary management: Effective at controlling the disease but not curative; lifelong compliance is required, and discontinuation results in return of hyperthyroidism [5].

Impact of Concurrent Disease on Prognosis: The most significant prognostic challenge is the interplay between hyperthyroidism and CKD [2][3]. A proportion of cats that appear to have normal renal function while hyperthyroid will develop overt CKD after treatment — this is because elevated GFR in the hyperthyroid state was compensating for underlying renal insufficiency [2][3]. Studies suggest that pre-treatment renal function and post-treatment creatinine/SDMA values are key prognostic determinants: cats that develop moderate-to-severe azotemia post-treatment have a guarded prognosis compared to those that remain non-azotemic [2][3].

Survival with Untreated or Poorly Controlled Hyperthyroidism: Untreated or inadequately managed hyperthyroidism leads to progressive cardiac disease, hypertension-related target organ damage (blindness, stroke, renal injury), severe cachexia, and eventually death. The median survival time without treatment is considerably shortened compared to treated cats.

Overall Long-term Survival: Hyperthyroid cats treated successfully with ¹³¹I or surgery and without significant concurrent disease can achieve median survival times of 2 years or more after diagnosis, with many cats living comfortably for 4–5 years post-treatment [4][5]. Quality of life improvements following effective treatment are consistently reported across all treatment modalities [5].

There is currently no proven preventive strategy that reliably prevents the development of feline hyperthyroidism; however, several evidence-informed management practices are recommended [4]:

• ·Regular wellness examinations and thyroid palpation: Annual or semi-annual veterinary examinations for cats over 7–8 years of age should include cervical palpation for thyroid enlargement and measurement of serum TT4 as part of a senior wellness panel, enabling early detection before severe clinical disease develops [4]
• ·Dietary considerations: Epidemiological evidence suggests associations between certain canned food varieties (particularly fish- and liver-based formulas), possible goitrogenic food additives (e.g., bisphenol A in can linings), and increased hyperthyroidism risk; however, evidence is insufficient to make definitive dietary prevention recommendations [4]
• ·Environmental considerations: Potential exposure to polybrominated diphenyl ethers (PBDEs) and other environmental disruptors in household dust and furnishings has been proposed as a contributing factor; minimizing dust exposure and ensuring good household ventilation may be prudent [4]
• ·Iodine balance in diet: Avoiding chronic dietary iodine excess or deficiency is theoretically prudent, though specific prevention recommendations are not yet established [4]
• ·No vaccine exists for feline hyperthyroidism, and the condition is non-contagious [4]
• ·Monitoring in at-risk cats: Older cats (>10 years), those with a known history of goiter, or cats with sibling/offspring affected by hyperthyroidism should receive more frequent thyroid screening [4]
• ·Comprehensive geriatric screening: Because hyperthyroidism frequently coexists with CKD, hypertension, and diabetes mellitus, thorough baseline diagnostics in geriatric cats allow earlier detection of all these conditions simultaneously [1][2]